Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Medicinal Chemistry 5-Day Program

11 Mar 2013 - 15 Mar 2013 - San Diego, CA, USA



Bookmark and Share


Save $200 when you enroll by February 1, 2013!!!!

About the Program
The Medicinal Chemistry 5-day program is designed to help you develop a comprehensive understanding of the drug discovery and development process.

Developed and taught by industry professionals, you will leave with an understanding of key concepts in medicinal chemistry, a reduced barrier to creative contribution and discussion with biological collaborators, and an increased awareness of the meaning and relevance of biological data.

Program Objectives

  • To teach the essential principles of drug discovery to biologists and chemists: In Vitro Predictors of In Vivo ADME
  • Facilitate collaboration and communication among pharmaceutical scientists.
  • To provide scientists with knowledge to help them reach their full potential.

Course Information

  • Dates/Time
    Monday - Friday, 8:00 a.m. - 5:00 p.m.
    March 11 - 15, 2013
  • Location
    UC San Diego Extension - University City Center
    6256 Greenwich Dr., San Diego, CA 92122
  • Fee
    $1,545 until February 1st ($200 savings!)
    $1,745 after February 1st
    (Continental breakfast and lunch is included)

To Register:
(858) 534-9999
http://extension.ucsd.edu/studyarea/index.cfm?vAction=singleCourse&vCourse=BIOL-40116
-Reference Section ID#: 093633 for $200 savings (expires Feb. 1st)
-Reference Section ID#: 092681 after Feb. 1st

Do you have 3 or more people from the same company who want to attend?
Call (858) 534-9353 or email unexbio@ucsd.edu to discuss additional benefits.

For more information:
Felicia Murray
(858) 534-9355
fimurray@ucsd.edu



Further information
Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Researchers Discover New Type of Mycovirus
Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!